Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

著者: Mario Castro, James Zangrilli, Michael E. Wechsler, Eric D. Bateman, Guy Brusselle, Philip G. Bardin, Kevin Murphy, Jorge Máspero, Christopher O’Brien, Stephanie Korn - The Lancet 2015 被引用: 1,173